Dechra Pharmaceuticals (LSE:DPH) FCF Margin % : -1.20% (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Dechra Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dechra Pharmaceuticals's Free Cash Flow for the six months ended in Jun. 2023 was £-4.6 Mil. Dechra Pharmaceuticals's Revenue for the six months ended in Jun. 2023 was £384.1 Mil. Therefore, Dechra Pharmaceuticals's FCF Margin % for the quarter that ended in Jun. 2023 was -1.20%.

As of today, Dechra Pharmaceuticals's current FCF Yield % is 0.76%.

The historical rank and industry rank for Dechra Pharmaceuticals's FCF Margin % or its related term are showing as below:

LSE:DPH' s FCF Margin % Range Over the Past 10 Years
Min: -7.52 Med: 11.71 Max: 18.59
Current: 4.37

During the past 13 years, the highest FCF Margin % of Dechra Pharmaceuticals was 18.59%. The lowest was -7.52%. And the median was 11.71%.

LSE:DPH's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.68 vs LSE:DPH: 4.37

Dechra Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Dechra Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dechra Pharmaceuticals FCF Margin % Chart

Dechra Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

12.31

11.10

-7.52

6.64

4.37

Dechra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial															3.99	11.61	1.92	10.04	-1.20

Competitive Comparison of Dechra Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dechra Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Dechra Pharmaceuticals's FCF Margin % falls into.

Dechra Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Dechra Pharmaceuticals's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	33.3	/	761.5
	=	4.37 %

Dechra Pharmaceuticals's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-4.6	/	384.1
	=	-1.20 %

Dechra Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Dechra Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dechra Pharmaceuticals (LSE:DPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

DPHAY:USA DPHl:UK 1PK:Germany

Address

24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA

Website

https://www.dechra.com

Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (LSE:DPH) Headlines

No Headlines